Intraocular Pressure Elevation (Glaucoma)

Overview

Glaucoma is a group of eye disorders characterized by progressive damage to the optic nerve, most often associated with elevated intraocular pressure (IOP). While high IOP is not the sole cause, it is the most important modifiable risk factor. If left untreated, glaucoma can lead to irreversible vision loss and blindness.

Who it affects: Glaucoma can develop at any age, but it is most common in adults over 40. Primary open‑angle glaucoma (POAG) accounts for roughly 70 % of cases in the United States, whereas angle‑closure glaucoma is less common but can present as an ocular emergency.

Prevalence: According to the World Health Organization (WHO), over 76 million people worldwide have some form of glaucoma, and the disease is the second leading cause of blindness globally. In the United States, the CDC estimates that about 3 million adults over 40 have glaucoma, with African‑American individuals experiencing a prevalence up to 5‑times higher than Caucasians.¹

Symptoms

Glaucoma often progresses silently. Symptoms may vary by type:

• Peripheral vision loss – “tunnel vision” that begins with loss of side vision and gradually spreads.
• Blurred or hazy vision – Particularly in low‑light conditions.
• Halos around lights – Common in acute angle‑closure attacks.
• Eye pain or headache – Sudden, severe pain is typical for acute angle‑closure glaucoma.
• Redness of the eye – Conjunctival injection may accompany angle‑closure attacks.
• Nausea and vomiting – Reflex response to sudden rise in IOP.
• Decreased visual acuity – Often a late sign when central vision is threatened.

Because many forms are asymptomatic, routine eye examinations are essential for early detection.

Causes and Risk Factors

Primary mechanisms

1. Impaired aqueous humor outflow – The fluid that nourishes the eye normally drains through the trabecular meshwork. Blockage or reduced permeability raises IOP.
2. Overproduction of aqueous humor – Less common, but excessive fluid production can increase pressure.
3. Anatomical predisposition – A shallow anterior chamber or narrow angle predisposes to angle‑closure glaucoma.

Key risk factors

• Age ≥ 40 years (risk doubles every decade after 40).
• Family history of glaucoma (first‑degree relative).
• African‑American, Hispanic, or Asian ancestry (higher prevalence of open‑angle and angle‑closure types respectively).
• High baseline intraocular pressure (>21 mm Hg).
• Myopia (nearsightedness) – especially for open‑angle glaucoma.
• Thin central corneal thickness – can mask true IOP readings.
• Systemic conditions: diabetes, hypertension, and hypothyroidism.
• Long‑term corticosteroid use (topical, oral, or inhaled).
• History of eye trauma or intra‑ocular surgery.

Diagnosis

Glaucoma diagnosis is a multi‑step process that combines pressure measurement, structural assessment, and functional testing.

1. Tonometry

Measures IOP. Goldmann applanation tonometry is the clinical gold standard; normal values are 10–21 mm Hg. A single high reading does not confirm disease, but persistently elevated readings warrant further work‑up.

2. Gonioscopy

Uses a special contact lens to visualize the angle between the cornea and iris. Determines whether the glaucoma is open‑angle or angle‑closure.

3. Ophthalmic Imaging

• Optical Coherence Tomography (OCT) – Provides high‑resolution cross‑sectional images of the retinal nerve fiber layer (RNFL) and optic nerve head.
• Scanning Laser Polarimetry – Assesses RNFL thickness.
• Heidelberg Retina Tomograph (HRT) – Offers three‑dimensional topography of the optic disc.

4. Visual Field Testing

Standard automated perimetry (e.g., Humphrey Field Analyzer) maps peripheral vision loss. Early defects often appear as “nasal steps” or “arcuate scotomas.”

5. Additional Assessments

• Fundoscopic examination of the optic disc for cupping.
• Pachymetry – measures corneal thickness to adjust IOP interpretation.
• Blood pressure and blood glucose checks if systemic risk factors are present.

Treatment Options

Therapy aims to lower IOP to a level that halts further optic nerve damage. Choice of treatment depends on the type and severity of glaucoma, patient tolerance, and comorbidities.

Medications

Topical eye drops are first‑line for most patients.

• Prostaglandin analogs (e.g., latanoprost, bimatoprost) – Increase uveoscleral outflow; once‑daily dosing.
• Beta‑blockers (e.g., timolol) – Reduce aqueous production; caution in asthma or severe COPD.
• Alpha‑agonists (e.g., brimonidine) – Dual action: decreased production & increased outflow.
• Carbonic anhydrase inhibitors (e.g., dorzolamide, oral acetazolamide) – Reduce fluid production; oral forms used in emergencies.
• Rho‑kinase inhibitors (e.g., netarsudil) – Newer class that enhances trabecular outflow.

Common side effects include ocular redness, hyperemia, dry eye, and, rarely, systemic effects such as bradycardia with beta‑blockers.

Surgical & Laser Procedures

1. Selective Laser Trabeculoplasty (SLT) – Uses low‑energy laser to improve trabecular outflow; repeatable.
2. Argon Laser Peripheral Iridotomy (ALPI) – Creates a small hole in the peripheral iris to relieve angle blockage (primarily for angle‑closure).
3. Trabeculectomy – Creates a new drainage pathway (bleb) under the conjunctiva; gold standard for advanced disease.
4. Glaucoma Drainage Devices (tube shunts) – Implanted tubes divert aqueous humor to an external reservoir.
5. Minimally Invasive Glaucoma Surgery (MIGS) – Stents or micro‑hooks placed ab interno; lower complication rates, often combined with cataract surgery.

Lifestyle & Adjunct Measures

• Maintain a healthy weight and regular aerobic exercise – modestly lowers IOP.
• Limit caffeine intake; excessive caffeine can transiently raise IOP.
• Avoid smoking – improves overall ocular blood flow.
• Adhere to medication schedule; use reminders or pill‑boxes.

Living with Intraocular Pressure Elevation (Glaucoma)

Successful management involves more than medication; it requires daily habits and regular monitoring.

Practical Tips

1. Schedule regular eye exams – At least once every 6–12 months, or as advised by your ophthalmologist.
2. Use drops correctly – Wash hands, avoid touching the tip, apply the drop, and press the inner canthus for 1–2 minutes to improve absorption.
3. Track IOP readings – Some practices provide home tonometry devices; keep a log.
4. Protect your eyes – Wear UV‑blocking sunglasses; avoid high‑impact sports without proper eye protection.
5. Manage systemic health – Keep blood pressure and blood sugar within target ranges.
6. Stay informed – Join support groups or follow reputable organizations (Glaucoma Research Foundation, American Academy of Ophthalmology).

Psychosocial Aspects

Vision loss can cause anxiety and depression. Early counseling, low‑vision rehabilitation services, and assistive technology (e.g., screen readers, magnifiers) improve quality of life.

Prevention

While genetic predisposition cannot be changed, many modifiable factors can reduce risk or delay onset.

• Regular comprehensive dilated eye exams starting at age 40 (earlier for high‑risk groups).
• Control blood pressure, blood glucose, and cholesterol.
• Limit long‑term corticosteroid exposure; discuss alternatives with your physician.
• Maintain a diet rich in omega‑3 fatty acids, leafy greens, and antioxidants – may support optic nerve health.
• Stay physically active – aerobic exercise 3–5 times per week can lower IOP by 1–4 mm Hg.
• Avoid heavy lifting or straining positions that can momentarily increase IOP.

Complications

If intraocular pressure remains uncontrolled, the following complications may arise:

• Progressive optic neuropathy – Irreversible loss of retinal ganglion cells.
• Visual field constriction – “Tunnel vision” that impairs driving, reading, and mobility.
• Legal blindness – Defined as visual acuity worse than 20/200 or visual field < 20°.
• Secondary ocular conditions – Including cataract formation (especially with steroid use) and corneal decompensation after certain surgeries.
• Psychological impact – Reduced independence, increased fall risk, depression.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Glaucoma. https://www.cdc.gov/visionhealth/glaucoma.htm. Accessed June 2024.
2. Mayo Clinic. Glaucoma – Symptoms and causes. https://www.mayoclinic.org. Updated 2023.
3. World Health Organization. World report on vision. 2022. https://www.who.int.
4. American Academy of Ophthalmology. Preferred Practice Pattern: Primary Open‑Angle Glaucoma. 2023. https://www.aao.org.
5. National Eye Institute (NIH). Glaucoma. https://www.nei.nih.gov. Updated 2024.